Anti-inflammatory drugs may up survival from severe malaria
Washington: A new anti-inflammatory drug could help boost survival in the most severe cases of malaria by preventing the immune system from causing irreversible brain and tissue damage, according to the researchers.
Walter and Eliza Hall Institute researchers have revealed that a new class of anti-inflammatory agents, called IDR (innate defense regulator) peptides, could help to increase survival from severe clinical malaria when used in combination with antimalarial drugs.
The study was conducted by a research team fronted by Dr Ariel Achtman and Dr Sandra Pilat-Carotta, and led by Professor Louis Schofield from the institute`s Infection and Immunity division.
Achtman claimed that many drugs that prevent malaria infections are not effective in sick patients at preventing tissue damage that arises from the inflammatory immune response.
"The most severe forms of malaria, such as cerebral malaria which causes brain damage, are actually the result of the immune system trying to fight infection and causing collateral damage," she said.
Pilat-Carotta said that the team used a treatment approach which combined drugs that suppress potentially harmful inflammation with antimalarial agents that fight the parasite, in mouse models infected with the malaria parasite Plasmodium berghei.
"In this study, we showed that a new class of drugs could prevent inflammation in the brains of mice with malaria and improve their survival. This is an example of a ``host-directed`` therapy – a treatment intended to act on the host not the parasite," Pilat-Carotta said.
Every year malaria kills up to one million people worldwide, particularly children under five and pregnant women, who often develop severe clinical symptoms such as, brain damage and multiple organ failure.
Professor Schofield claimed that up to 25 per cent of severe clinical malaria cases are fatal even with access to the best health care.
"Antimalarial drugs are very effective, but only if they are given before serious clinical symptoms develop. On their own, antimalarial drugs fail in approximately one out of every four cases of severe clinical malaria, because by the time the patient arrives at a hospital they are already very sick and inflammation caused by the immune response to the parasite is causing major organ damage," Schofield said.
Schofield revealed that IDR peptides are a new class of anti-inflammatory agent developed by Professor Robert Hancock and colleagues at the University of British Columbia, Canada, which enhance beneficial aspects of the initial immune response, while dampening harmful inflammation.
"IDR peptides are also relatively cheap to produce and easy to use, making them a good option for medical treatments in developing countries," he said.
Achtman insisted that the development of preclinical models of severe malaria could improve pre-clinical drug screening and potentially prevent some of the drug failures that happen at the human clinical trial stage.
"Professor Gordon Smyth and Ms Charity Law from the institute`s Bioinformatics division used sophisticated bioinformatics-driven analyses to identify early changes to inflammatory processes, days before the mice show visible changes in malaria disease symptoms. Host-directed therapies are a good treatment option because parasites are less likely to evolve resistance, and we believe they will eventually increase the number of successful treatment interventions in the short time window between hospitalisation with severe malaria and death," said Achtman.
This study has been published in the journal Science Translational Medicine.
More from India
More from World
More from Sports
More from Entertaiment
- One year of Modi govt: PM promises to fulfil aspirations
- DNA: Sikh man in New Zealand removed his turban to help injured kid
- Watch: Mumbai cops find new secret agents in housewives!
- Hundreds die as heat wave continues in India
- 2G scam: Ex-TRAI chief alleges Manmohan Singh had warned him to cooperate
- DNA: AIIMS doctor removes both kidneys of minor, claims she had only one
- Pranab Mukherjee defends Bofors scam, says it was just a media trial
- Salman Khan attends sister Arpita's wedding reception in Mandi
- Zee Media's mega survey on Modi govt
- Zee Media Exclusive: Vidya Balan chats about 'Hamari Adhuri Kahani'
- Para athlete Deepa Malik complains of callous service by Air India
- Smriti Irani visits Amethi, promises to pay insurance money to 25,000 women
- One year of Modi govt: Amit Shah addresses media
- Delhi: Visually impaired boy scores 91.4% in CBSE 12th Board exams
- Mathura rally: PM Modi's ten power-packed dialogues
- One year of NDA govt: PM Modi writes open letter to nation, promises to transform India
- Arpita-Aayush wedding reception: Salman Khan spreads love in Mandi, says `hum aapke hain`
- World optimistic about India: PM Narendra Modi on 1 year of NDA govt
- MSBSHSE Class 12th HSC results 2015 to be declared at 1pm tomorrow
- Bharatiya Janata Party lacks majority for Ram Temple, Article 370: Amit Shah
- Rahul Gandhi takes a dig at one year of Modi govt, wishes 'happy birthday' to 'suit-boot ki sarkar'
- AAP govt moves resolution against MHA notification: As it happened
- CBSE Class 10 Board Result 2015 (cbse.nic.in, cbseresults.nic.in) postponed?
- Check mahresult.nic.in for MSBSHSE Maharashtra Class 12 HSC Result 2015
- Maharashtra MSBSHSE HSC Result 2015 on mahresult.nic.in
- Heatwave kills 90 more in Andhra, Telangana; toll crosses 800
- UBSE Results 2015 (ubse.uk.gov.in): Uttarakhand 12th Result 2015 to be announced today at 11 AM
- CBSE Class 10 Board Result 2015 to be announced on May 28
- Gujjars adamant on holding talks in Bayana; rail tracks remain blocked
- CBSE 10th result to be declared tomorrow